Showing results (791-800 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|August 13, 2017
Does Dose Modification Affect Efficacy of First-Line Pazopanib in Metastatic Renal Cell Carcinoma?Paolo Grassi, Elena Verzoni, Raffaele Ratta, et al.Drugs in R&D|September 14, 2015
A Dose-Finding Study of Dexketoprofen in Patients Undergoing Laparoscopic Cholecystectomy: A Randomized Clinical Trial on Effects on the Analgesic Concentration of OxycodoneAnnika Piirainen, Hannu Kokki, Satu Immonen, et al.Drugs in R&D|August 9, 2015
Imeglimin: A Potential New Multi-Target Drug for Type 2 DiabetesValerie Vuylsteke, Lisa M Chastain, Geeta A Maggu, et al.Drugs in R&D|July 26, 2017
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset SeizuresGraciana L Galiana, Angela C Gauthier, Richard H MattsonDrugs in R&D|November 21, 2015
Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine-Pyrimethamine Disposition Among Ugandan Pregnant WomenCharles O Odongo, Kuteesa R Bisaso, Muhammad Ntale, et al.Drugs in R&D|December 7, 2017
Efficacy and Safety of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis: An UpdateJosé Antonio Rodríguez-PortalDrugs in R&D|September 7, 2017
Boceprevir and Antiretroviral Pharmacokinetic Interactions in HIV/HCV Co-infected Persons: AIDS Clinical Trials Group Study A5309sJennifer J Kiser, Darlene Lu, Susan L Rosenkranz, et al.Drugs in R&D|September 8, 2017
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell LinesXi Zhang, Simone Hofmann, Nadia Harbeck, et al.Drugs in R&D|November 6, 2017
A Randomized Multiple Dose Pharmacokinetic Study of a Novel PDE10A Inhibitor TAK-063 in Subjects with Stable Schizophrenia and Japanese Subjects and Modeling of Exposure Relationships to Adverse EventsPaul Goldsmith, John Affinito, Maggie McCue, et al.Drugs in R&D|January 17, 2019
Assessment of Taste and Grittiness of Riomet® ER Strawberry, Riomet® ER Grape, Riomet® Cherry, and Metformin Immediate-Release Tablets in Healthy SubjectsAllyson C Marshall, Maureen Damstra, Michael Tuley, et al.Pageof 89